Journal of the American Medical Association (JAMA)

publication venue for

Early Metformin in Gestational Diabetes 2023
Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial.. 332:1808-1821. 2024
Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.. 333. 2024
Tranexamic Acid in Patients Undergoing Liver Resection: The HeLiX Randomized Clinical Trial.. 332:1080-1089. 2024
Perioperative Management of Patients Taking Direct Oral Anticoagulants. 332:825-834. 2024
Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence. 332. 2024
Hypertension and Kidney Function After Living Kidney Donation. 332:287-287. 2024
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome. 332:204-204. 2024
Mortality and Morbidity in Adults With Rheumatic Heart Disease. 332:133-133. 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure. 331:2094-2094. 2024
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy. 331:573-573. 2024
Gefapixant for Chronic Cough—Reply. 331:530-530. 2024
Red Blood Cell Transfusion. 330:1892-1892. 2023
Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care. 330:1872-1872. 2023
Intravenous Vitamin C for Patients Hospitalized With COVID-19. 330:1745-1745. 2023
Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough. 330:1359-1359. 2023
Global Variations in Heart Failure—Reply. 330:1192-1192. 2023
The mutterseelenallein. 330:773-773. 2023
Global Variations in Heart Failure Etiology, Management, and Outcomes. 329:1650-1650. 2023
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy. 329:1579-1579. 2023
Spinal Cord Burst Stimulation vs Placebo Stimulation for Patients With Chronic Radicular Pain After Lumbar Spine Surgery. 329:846-846. 2023
Guidelines for Reporting Outcomes in Trial Protocols. 328:2345-2345. 2022
Guidelines for Reporting Outcomes in Trial Reports. 328:2252-2252. 2022
Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation. 328:1922-1922. 2022
Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness. 328:1827-1827. 2022
Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy. 328:1326-1326. 2022
Thromboprophylaxis After Hip or Knee Arthroplasty. 328:712-712. 2022
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure. 327:2104-2104. 2022
Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. 327:1963-1963. 2022
Clarification of Conflict Management in Users’ Guide. 327:784-784. 2022
Controversies About Advance Care Planning. 327:684-684. 2022
Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients—Reply. 327:182-182. 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism. 327:129-129. 2022
How to Use and Interpret the Results of a Platform Trial. 327:67-67. 2022
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19. 326:1690-1690. 2021
How to Interpret and Use a Clinical Practice Guideline or Recommendation. 326:1516-1516. 2021
Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients. 326:1024-1024. 2021
Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma. 325:2466-2466. 2021
S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021. 325:2115-2115. 2021
Ventilator Weaning and Discontinuation Practices for Critically Ill Patients. 325:1173-1173. 2021
Peripheral Oxygen Saturation in Older Persons Wearing Nonmedical Face Masks in Community Settings. 324:2323-2323. 2020
Intimate Partner Violence. 324:1201-1201. 2020
Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure. 324:57-57. 2020
Home Noninvasive Positive Pressure Ventilation for Chronic Obstructive Pulmonary Disease. 323:2432-2432. 2020
Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment. 323:1934-1934. 2020
Critical Illness in Patients With COVID-19. 323:1559-1559. 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty. 323:130-130. 2020
Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure. 322:2292-2292. 2019
Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients. 322:2179-2179. 2019
Association of Baclofen With Encephalopathy in Patients With Chronic Kidney Disease. 322:1987-1987. 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery. 322:1966-1966. 2019
Family Visitation Policies in the ICU and Delirium—Reply. 322:1924-1924. 2019
Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation. 322:1105-1105. 2019
Incorporating Intimate Partner Violence Interventions in Nurse Home Visitation Programs—Reply. 322:1103-1103. 2019
Evidence vs Consensus in Clinical Practice Guidelines. 322:725-725. 2019
Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit. 322:216-216. 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy. 321:1993-1993. 2019
Meta-analysis of Opioids for Chronic Pain—Reply. 321:1936-1936. 2019
Canada’s Amendment to Patented Drug Price Regulation. 321:1565-1565. 2019
Effect of Addition of an Intimate Partner Violence Intervention to a Nurse Home Visitation Program on Maternal Quality of Life. 321:1576-1576. 2019
Safeguarding the Patient’s Own Blood Supply. 321:943-943. 2019
Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure–Guided Strategy vs an Empirical High PEEP-Fio₂ Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome. 321:846-846. 2019
Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure. 321:753-753. 2019
Effect of a Nurse-Led Preventive Psychological Intervention on Symptoms of Posttraumatic Stress Disorder Among Critically Ill Patients. 321:665-665. 2019
Serum Creatinine Levels Before, During, and After Pregnancy. 321:205-205. 2019
Diagnostic vs Management Reasoning—Reply. 320:1818-1818. 2018
Global Mortality From Firearms, 1990-2016. 320:792-792. 2018
Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics. 320:499-499. 2018
Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy. 319:2437-2437. 2018
Management Reasoning. 319:2267-2267. 2018
Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. 319:2190-2190. 2018
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock. 319:1889-1889. 2018
Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease. 319:1870-1870. 2018
Association of Solid Fuel Use With Risk of Cardiovascular and All-Cause Mortality in Rural China. 319:1351-1351. 2018
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants. 319:1221-1221. 2018
Effect of a Pediatric Early Warning System on All-Cause Mortality in Hospitalized Pediatric Patients. 319:1002-1002. 2018
Absolute vs Additive Net Reclassification Index—Reply. 319:617-617. 2018
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes. 319:38-38. 2018
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. 320:2448-2460. 2018
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma. 318:2306-2306. 2017
Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery. 318:1994-1994. 2017
Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. 318:1913-1913. 2017
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes. 318:1891-1891. 2017
Association Between Prepregnancy Body Mass Index and Severe Maternal Morbidity. 318:1777-1777. 2017
Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury. 318:1787-1787. 2017
Comparisons of Interventions for Preventing Falls in Older Adults. 318:1687-1687. 2017
Discrimination and Calibration of Clinical Prediction Models. 318:1377-1377. 2017
Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome. 318:1335-1335. 2017
High-Sensitivity Troponin Levels, Ischemia, and Mortality—Reply. 318:865-865. 2017
Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children. 318:245-245. 2017
Adjustment Strategies in Studies of Therapy—Reply. 317:2238-2238. 2017
Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. 317:1642-1642. 2017
Adjusted Analyses in Studies Addressing Therapy and Harm. 317:748-748. 2017
Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. 317:269-269. 2017
Clinical Practice Guidelines From the AABB. 316:2025-2025. 2016
Effect of Supplemental Donor Human Milk Compared With Preterm Formula on Neurodevelopment of Very Low-Birth-Weight Infants at 18 Months. 316:1897-1897. 2016
Probiotics and the Prevention of Antibiotic-Associated Diarrhea in Infants and Children. 316:1484-1484. 2016
Colchicine and Prevention of Cardiovascular Events. 316:1106-1106. 2016
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses. 316:1093-1093. 2016
Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants. 316:611-611. 2016
Management of Community-Acquired Pneumonia. 316:221-221. 2016
Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis. 315:1966-1966. 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance. 315:1580-1580. 2016
Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED. 315:1014-1014. 2016
Hip Fracture Surgery vs Elective Total Hip Replacement—Reply. 315:942-942. 2016
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection. 315:142-142. 2016
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure. 315:164-164. 2016
Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia. 314:2514-2514. 2015
Endovascular Thrombectomy for Acute Ischemic Stroke. 314:1832-1832. 2015
Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement. 314:1159-1159. 2015
Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. 314:895-895. 2015
Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants. 314:595-595. 2015
Empirical Therapy of Community-Acquired Pneumonia. 314:396-396. 2015
Everything You Ever Wanted to Know About Evidence-based Medicine. 313:1783-1783. 2015
Perioperative Treatment With Aspirin or Clonidine and Risk of Acute Kidney Injury—Reply. 313:1166-1166. 2015
Effect of Scattered-Site Housing Using Rent Supplements and Intensive Case Management on Housing Stability Among Homeless Adults With Mental Illness. 313:905-905. 2015
Effect of Scattered-Site Housing Using Rent Supplements and Intensive Case Management on Housing Stability Among Homeless Adults With Mental Illness A Randomized Trial (vol 313, pg 905, 2015). 313:905-905. 2015
Ethical Testing of Experimental Ebola Treatments. 313:421-421. 2015
Ethical Testing of Experimental Ebola Treatments—Reply. 313:422-422. 2015
Heterogeneity in Meta-analysis of FDG-PET Studies to Diagnose Lung Cancer. 313:419-419. 2015
Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery. 313:1364-1365. 2015
Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury. 312:2254-2254. 2014
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients. 312:2135-2135. 2014
Evidence-Based Practice Is Not Synonymous With Delivery of Uniform Health Care. 312:1293-1293. 2014
PET Screening for Metastatic Colorectal Adenocarcinoma—Reply. 312:1256-1256. 2014
Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease. 312:1114-1114. 2014
Reanalyses of Randomized Clinical Trial Data. 312:1024-1024. 2014
Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults. 312:923-923. 2014
Effect of Oximetry on Hospitalization in Bronchiolitis. 312:712-712. 2014
Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke. 312:616-616. 2014
Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke (vol 312, pg 616, 2014). 312:A616-A616. 2014
Physician Registration for Deceased Organ Donation. 312:291-291. 2014
How to Read a Systematic Review and Meta-analysis and Apply the Results to Patient Care. 312:171-171. 2014
Does This Patient Have Generalized Anxiety or Panic Disorder?. 312:78-78. 2014
Incorrect Version of Table. 312:97-97. 2014
Kidney Function After Off-Pump or On-Pump Coronary Artery Bypass Graft Surgery. 311:2191-2191. 2014
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia. 311:1870-1870. 2014
Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases. 311:1863-1863. 2014
Pharmacological Treatment of Parkinson Disease. 311:1670-1670. 2014
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2). 311:692-692. 2014
Association Between Severe Retinopathy of Prematurity and Nonvisual Disabilities at Age 5 Years. 311:523-523. 2014
How to Use a Subgroup Analysis. 311:405-405. 2014
Prevalence, characteristics, and publication of discontinued randomized trials. 311:1045-1052. 2014
Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury. 310:2544-2544. 2013
Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation. 310:2050-2050. 2013
Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before. 310:1837-1837. 2013
Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICU. 310:1571-1580. 2013
Clinical Decision Rules to Rule Out Subarachnoid Hemorrhage for Acute Headache. 310:1248-1248. 2013
Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes. 310:1145-1145. 2013
Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. 310:959-959. 2013
Polypill for Cardiovascular Disease Prevention—Reply. 310:749-749. 2013
An Evidence-Based Response to Intimate Partner Violence. 310:479-479. 2013
Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. 309:2223-2223. 2013
Effects of Targeting Higher vs Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants. 309:2111-2111. 2013
Combination Therapy to Prevent Cardiovascular Disease. 309:1595-1595. 2013
Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries. 309:1613-1613. 2013
Medical School Admission Interview and Licensing Examination Scores—Reply. 309:1108-1108. 2013
Sedation Interruption for Mechanically Ventilated Patients—Reply. 309:982-982. 2013
Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections. 309:717-717. 2013
How to Use a Noninferiority Trial. 308:2605-2605. 2012
Partner Violence Screening and Women’s Quality of Life—Reply. 308:2334-2334. 2012
Association Between a Medical School Admission Process Using the Multiple Mini-interview and National Licensing Examination Scores. 308:2233-2233. 2012
Warfarin After Bioprosthetic Aortic Valve Implantation. 308:2147-2147. 2012
Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for With a Sedation Protocol. 308:1985-1985. 2012
Multivitamins in Prevention of Cardiovascular Disease. 308:1802-1802. 2012
How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis. 308:1246-1246. 2012
Troponin Levels and Mortality After Noncardiac Surgery—Reply. 308:1204-1204. 2012
Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction. 308:796-796. 2012
Health Care's Response to Women Exposed to Partner Violence. 308:712-712. 2012
Aging and HIV-Related Cognitive Loss. 308:349-349. 2012
Exposure to Nitrogen Dioxide in an Indoor Ice Arena-New Hampshire, 2011 (Reprinted from MMWR vol 61, pg 139, 2012). 308:230-232. 2012
Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’. 307:2590-2590. 2012
Incomplete Results Data in: Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. 307:2590-2590. 2012
Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. 307:2295-2295. 2012
A Train of Hope, and a Chance to Train. 307:2039-2040. 2012
Urinary Sodium Excretion and Cardiovascular Events—Reply. 307:1139-1139. 2012
Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity. 307:275-275. 2012
Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis. 307:294-303. 2012
Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events. 306:2229-2238. 2011
Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke. 306:2137-2144. 2011
Pharmaconutrition in Acute Lung Injury. 306:1599-1599. 2011
Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia. 306:831-839. 2011
Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation. 305:2080-2080. 2011
Highly Sensitive Cardiac Troponin T Assay, Cardiac Disease, and Mortality Risk. 305:1196-1196. 2011
Preventing Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis—Reply. 305:996-996. 2011
How to Use an Article About Quality Improvement. 304:2279-2279. 2010
Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis. 304:2145-2145. 2010
Out-of-Hospital Hypertonic Resuscitation Following Severe Traumatic Brain Injury. 304:1455-1455. 2010
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial. 304:1339-1349. 2010
Causes of Sudden Death During the Triathlon. 304:269-269. 2010
Bias and Trials Stopped Early for Benefit—Reply. 304:156-156. 2010
Influenza Vaccination of Children and Infection Rates in the Community—Reply. 303:2355-2355. 2010
Depression Severity and Effect of Antidepressant Medications. 303:1596-1596. 2010
Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy. 303:1603-1603. 2010
Does This Patient With Diabetes Have Large-Fiber Peripheral Neuropathy?. 303:1526-1526. 2010
Report Cards for Cardiac Care. 303:1367-1367. 2010
Health Behavior vs the Stress of Low Socioeconomic Status and Health Outcomes. 303:1199-1199. 2010
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects<subtitle>Systematic Review and Meta-regression Analysis</subtitle>. 303:1180-1180. 2010
Effect of Influenza Vaccination of Children on Infection Rates in Hutterite Communities. 303:943-943. 2010
Surgical Masks vs N95 Respirators for Preventing Influenza—Reply. 303:937-937. 2010
Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome. 303:865-865. 2010
Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women. 303:631-631. 2010
Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?. 303:446-446. 2010
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound. 303:438-438. 2010
Screening for Intimate Partner Violence—Reply. 302:2434-2434. 2009
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada. 302:1872-1872. 2009
Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico. 302:1880-1880. 2009
Surgical Mask vs N95 Respirator for Preventing Influenza Among Health Care Workers. 302:1865-1865. 2009
Comparisons of Citations in Web of Science, Scopus, and Google Scholar for Articles Published in General Medical Journals. 302:1092-1092. 2009
Genetic Modifiers of Liver Disease in Cystic Fibrosis. 302:1076-1076. 2009
Combined Corticosteroid and Antiviral Treatment for Bell Palsy. 302:985-985. 2009
Trends in Hip Fracture Rates in Canada. 302:883-883. 2009
Screening for Intimate Partner Violence in Health Care Settings<subtitle>A Randomized Trial</subtitle>. 302:493-493. 2009
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease. 302:37-37. 2009
Living With Uncertainty in the Intensive Care Unit. 301:2388-2388. 2009
Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery. 301:1991-1991. 2009
Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms? (vol 300, pg 1793, 2008). 301:1544-1544. 2009
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure. 301:1439-1439. 2009
Testing for Celiac Disease in Patients With Symptoms of Irritable Bowel Syndrome—Reply. 301:1126-1126. 2009
How to Use an Article About Genetic Association: A: Background Concepts (vol 301, pg 74, 2009). 301:1024-1024. 2009
Using N-of-1 Trials in Evidence-Based Clinical Practice Reply. 301:1023-1023. 2009
Internet-Based Education for Health Professionals—Reply. 301:598-598. 2009
How to Use an Article About Genetic Association. 301:304-304. 2009
How to Use an Article About Genetic Association. 301:191-191. 2009
How to Use an Article About Genetic Association. 301:74-74. 2009
Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women. 300:2489-2489. 2008
Incorporating Patient Preferences in Evidence-Based Medicine. 300:2483-2483. 2008
Progress in Evidence-Based Medicine. 300:1814-1814. 2008
Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms?. 300:1793-1793. 2008
Internet-Based Learning in the Health Professions. 300:1181-1181. 2008
Ventilation Strategies for Acute Lung Injury and Acute Respiratory Distress Syndrome—Reply. 300:39-39. 2008
Patient-Important Outcomes in Registered Diabetes Trials. 299:2543-2543. 2008
Glucose-Insulin-Potassium Therapy in Patients With STEMI—Reply. 299:2385-2385. 2008
Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention—Wrong Again?. 299:2086-2086. 2008
Ventilation Strategy Using Low Tidal Volumes, Recruitment Maneuvers, and High Positive End-Expiratory Pressure for Acute Lung Injury and Acute Respiratory Distress Syndrome. 299:637-637. 2008
Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction. 298:2399-2399. 2007
Lymph Node Counts in Colon Cancer Surgery. 298:2194-2194. 2007
Eligibility Criteria of Randomized Controlled Trials—Reply. 298:37-37. 2007
Eligibility criteria of randomized controlled trials - Reply [6]. 298:39-40. 2007
In reply [10]. 297:1881-1882. 2007
Pexelizumab and the APEX AMI Trial—Reply. 297:1877-1877. 2007
Risk Factors for Early Myocardial Infarction in South Asians—Reply. 297:1880-1880. 2007
Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals. 297:1233-1233. 2007
Late vs Early Clamping of the Umbilical Cord in Full-term Neonates. 297:1241-1241. 2007
Association Between Unreported Outcomes and Effect Size Estimates in Cochrane Meta-analyses. 297:465-465. 2007
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism—Reply. 297:261-261. 2007
Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries. 297:286-286. 2007
Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. 297:91-91. 2007
Acetaminophen and Aminotransferase Elevations. 296:2798-2798. 2006
Reducing Hospitalizations in Nursing Home Patients With Pneumonia—Reply. 296:2201-2201. 2006
Fondaparinux in Patients With ST-Segment Elevation Myocardial Infarction—Reply. 296:2087-2087. 2006
In reply [4]. 296:2088-2089. 2006
Distinguishing Organic and Functional Dyspepsia by History. 296:1352-1352. 2006
In reply [8]. 296:1352-1353. 2006
Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease. 296:1377-1377. 2006
Antiarrhythmic Therapy for Prevention of Implantable Cardioverter Defibrillator Shocks—Reply. 296:1229-1229. 2006
In reply [3]. 296:1230. 2006
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism. 296:935-935. 2006
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America. 296:679-679. 2006
Approaches to Screening for Intimate Partner Violence in Health Care Settings. 296:530-530. 2006
Medical Management of Peripheral Arterial Disease—Reply. 296:41-41. 2006
Treatment of Antiphospholipid Antibody Syndrome—Reply. 296:42-42. 2006
Transition to Adulthood for Extremely Low-Birth-Weight Infants—Reply. 295:2603-2603. 2006
Effect of a Clinical Pathway to Reduce Hospitalizations in Nursing Home Residents With Pneumonia. 295:2503-2503. 2006
Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes. 295:2046-2046. 2006
Second-Order Peer Review of the Medical Literature for Clinical Practitioners. 295:1801-1801. 2006
Can the Clinical History Distinguish Between Organic and Functional Dyspepsia?. 295:1566-1566. 2006
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial. 295:1519-1530. 2006
Intravenous Morphine and Topical Tetracaine for Treatment of Pain in Preterm Neonates Undergoing Central Line Placement—Correction. 295:1518-1518. 2006
Management of Antiphospholipid Antibody Syndrome. 295:1050-1050. 2006
Intravenous Morphine and Topical Tetracaine for Treatment of Pain in Preterm Neonates Undergoing Central Line Placement. 295:793-793. 2006
Transition of Extremely Low-Birth-Weight Infants From Adolescence to Young Adulthood. 295:667-667. 2006
Does the Clinical Examination Predict Lower Extremity Peripheral Arterial Disease?. 295:536-536. 2006
Medical Treatment of Peripheral Arterial Disease. 295:547-547. 2006
Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators<SUBTITLE>The OPTIC Study: A Randomized Trial</SUBTITLE>. 295:165-165. 2006
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis. 295:180-180. 2006
Routine vs Selective Invasive Strategies in Acute Coronary Syndromes. 294:2844-2844. 2005
Routine vs Selective Invasive Strategies in Acute Coronary Syndromes—Reply. 294:2844-2844. 2005
Ventilatory Management of Acute Lung Injury and Acute Respiratory Distress Syndrome. 294:2889-2889. 2005
Randomized Trials Stopped Early for Benefit. 294:2203-2203. 2005
Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure. 294:1794-1794. 2005
Family Violence Research. 294:618-618. 2005
Vitamin E Supplementation, Cardiovascular Events, and Cancer—Reply. 294:425-425. 2005
Outcomes for Extremely Low-Birth-Weight Infants. 294:371-371. 2005
Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes. 293:2908-2908. 2005
Glucose-Insulin-Potassium Infusion and Mortality in the CREATE-ECLA Trial—Reply. 293:2596-2596. 2005
Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.. 293:2596-2597. 2005
Reviparin in Acute Myocardial Infarction—Reply. 293:2595-2595. 2005
Reviparin in acute myocardial infarction.. 293:2595. 2005
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer. 293:1338-1338. 2005
Effects of long-term supplementation on and cancer vitamin E cardiovascular events - A randomized controlled trial. 293:1338-1347. 2005
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes. 293:1223-1223. 2005
Oral Antiplatelet Therapy—Reply. 293:793-793. 2005
Oral antiplatelet therapy.. 293:793-794. 2005
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction. 293:437-437. 2005
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation. 293:427-427. 2005
History of Emerging Vascular Disease Risk Factors. 292:2086-2086. 2004
History of Emerging Vascular Disease Risk Factors—Reply. 292:2086-2086. 2004
Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease. 292:1867-1867. 2004
Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery. 292:435-435. 2004
Novel Risk Factors for Atherosclerosis. 291:301-301. 2004
Novel Risk Factors for Atherosclerosis—Reply. 291:301-301. 2004
Novel risk factors for atherosclerosis.. 291:301. 2004
Premature application of trial results to clinical practice - Reply. 290:3072-3072. 2003
Does This Patient Have Pulmonary Embolism?. 290:2849-2849. 2003
The Arc of the Pulmonary Artery Catheter. 290:2732-2732. 2003
Diagnosis and Management of Female Infertility. 290:1767-1767. 2003
Ethical Aspects in Trials of Implantable Medical Devices. 290:1579-1579. 2003
Ethical Aspects in Trials of Implantable Medical Devices—Reply. 290:1579-1579. 2003
Effect of Awareness of a Randomized Controlled Trial on Use of Experimental Therapy. 290:1351-1351. 2003
Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome. 290:1360-1360. 2003
Emerging Risk Factors for Atherosclerotic Vascular Disease. 290:932-932. 2003
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein. 290:502-502. 2003
Critically Ill Patients With Severe Acute Respiratory Syndrome. 290:367-367. 2003
Unraveling Severe Sepsis. 290:256-256. 2003
Quality of Care in Profit vs Not-For-Profit Dialysis Centers. 289:3087-3087. 2003
Quality of care in profit vs not-for-profit dialysis centers - Reply. 289:3089-3090. 2003
Effect of Industry Sponsorship on the Results of Biomedical Research. 289:2502-2503. 2003
Intervening in Abusive Relationships—Reply. 289:2211-2211. 2003
Intervening in abusive relationships - Reply. 289:2211-2212. 2003
Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope. 289:2224-2224. 2003
Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions. 289:1941-1941. 2003
Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months. 289:1124-1124. 2003
Interventions for Violence Against Women. 289:589-589. 2003
El Niño and Incidence of Hemorrhagic Fever With Renal Syndrome in China. 289:176-176. 2003
Cultural Diversity: An Evolving Challenge to Physician-Patient Communication. 289:94-94. 2003
Risk Communication: Problems of Presentation and Understanding. 289:95-95. 2003
Helping Patients Follow Prescribed Treatment. 288:2880-2880. 2002
Interventions to Enhance Patient Adherence to Medication Prescriptions. 288:2868-2868. 2002
Prematurity and Later Cognitive Outcomes. 288:2542-2542. 2002
Prematurity and Later Cognitive Outcomes. 288:2542-2543. 2002
Protocols to Improve the Care of Critically Ill Pediatric and Adult Patients. 288:2601-2601. 2002
Comparison of Mortality Between Private For-Profit and Private Not-For-Profit Hemodialysis Centers. 288:2449-2449. 2002
Effectiveness of Nurses as Providers of Birth Labor Support in North American Hospitals<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>. 288:1373-1373. 2002
Prognosis for Gross Motor Function in Cerebral Palsy. 288:1357-1357. 2002
Evaluating the Teaching of Evidence-Based Medicine. 288:1110-1110. 2002
Pollution-Related Mortality and Educational Level. 288:830-830. 2002
Analysis of Cases of Harm Associated With Use of Health Information on the Internet. 287:2869-2869. 2002
Association Between Time Interval to Publication and Statistical Significance. 287:2829-2829. 2002
Comparison of Review Articles Published in Peer-Reviewed and Throwaway Journals. 287:2853-2853. 2002
Publication Bias in Editorial Decision Making. 287:2825-2825. 2002
Outcomes at 3 Months After Planned Cesarean vs Planned Vaginal Delivery for Breech Presentation at Term<SUBTITLE>The International Randomized Term Breech Trial</SUBTITLE>. 287:1822-1822. 2002
Characteristics and Outcomes in Adult Patients Receiving Mechanical Ventilation<SUBTITLE>A 28-Day International Study</SUBTITLE>. 287:345-345. 2002
Ramipril and Risk of Diabetes—Reply. 287:186-186. 2002
Continuing Challenges of Sepsis Research. 286:1894-1894. 2001
Ramipril and the Development of Diabetes. 286:1882-1882. 2001
Internet Use Among Physicians, Nurses, and Their Patients. 286:1451-1452. 2001
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals. 286:421-421. 2001
Cost-Sharing for Prescription Drugs. 285:2328-2328. 2001
Safety of Bolus vs Infusion Thrombolytic Therapy. 285:2075-2075. 2001
Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials. 285:2000-2000. 2001
Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons. 285:421-421. 2001
Safety Outcomes in Meta-analyses of Phase 2 vs Phase 3 Randomized Trials. 285:444-444. 2001
What Is the Best Evidence for Making Clinical Decisions?. 284:3127-3128. 2000
Helping Patients Integrate Research Evidence. 284:2594-2595. 2000
Helping Patients Integrate Research Evidence—Reply. 284:2594-2594. 2000
Helping patients integrate research evidence - Reply. 284:2595-2595. 2000
Users' Guides to the Medical Literature. 284:1290-1290. 2000
Users' Guides to the Medical Literature. 284:869-869. 2000
Users' Guides to the Medical Literature. 284:478-482. 2000
Users' Guides to the Medical Literature. 284:357-357. 2000
Users' Guides to the Medical Literature. 284:79-79. 2000
Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group.. 284:79-84. 2000
Informed Decisions for Extremely Low-Birth-Weight Infants. 283:3201-3202. 2000
Users' Guides to the Medical Literature. 283:2829-2829. 2000
Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction. 283:2686-2686. 2000
Intra-arterial Prourokinase for Acute Ischemic Stroke. 283:2102-2104. 2000
Users' Guides to the Medical Literature. 283:1875-1875. 2000
Users' guides to the medical literature - XXI. Using electronic health information resources in evidence-based practice. 283:1875-1879. 2000
Systematic Implementation of an Advance Directive Program in Nursing Homes. 283:1437-1437. 2000
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis. 282:2058-2058. 1999
Users' Guides to the Medical Literature. 282:771-771. 1999
Does This Adult Patient Have Acute Meningitis?. 282:175-175. 1999
Users' Guides to the Medical Literature. 282:67-67. 1999
A 75-Year-Old Man With Congestive Heart Failure. 281:2321-2321. 1999
Differences in Preferences for Neonatal Outcomes Among Health Care Professionals, Parents, and Adolescents. 281:1991-1991. 1999
Users' Guides to the Medical Literature. 281:2029-2029. 1999
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.. 281:2029-2034. 1999
The Trials and Tribulations of Clinical Practice Guidelines. 281:1950-1950. 1999
Users' Guides to the Medical Literature<SUBTITLE>XVI. How to Use a Treatment Recommendation</SUBTITLE>. 281:1836-1836. 1999
Influence of Hospital Volume on Mortality Following Major Cancer Surgery. 281:1374-1374. 1999
Influence of hospital volume on mortality following major cancer surgery.. 281:1374. 1999
Users' Guides to the Medical Literature. 281:1214-1214. 1999
Diagnosing myocardial infarction: should patients carry a copy of their ECG?. 281:705. 1999
JAMA and Editorial Independence. 281:460-460. 1999
Plasma D-Dimer in the Diagnosis of Deep Vein Thrombosis. 280:1828-1829. 1998
Plasma D-dimer in the diagnosis of deep vein thrombosis - Reply. 280:1829-1829. 1998
Applicability of clinical trial results to primary care - Reply. 280:1746-1746. 1998
Effects of Computer-Based Clinical Decision Support Systems on Physician Performance and Patient Outcomes. 280:1339-1339. 1998
Is This Patient Having a Myocardial Infarction?. 280:1256-1256. 1998
Antisecretory Therapy for Bleeding Peptic Ulcer. 280:877-877. 1998
Methodology and Reports of Systematic Reviews and Meta-analyses. 280:278-278. 1998
Caring for the Critically Ill Patient. 280:181-181. 1998
Does this patient have deep vein thrombosis? (vol 279, pg 1094, 1998). 279:1614-1614. 1998
Fatal Residential Fires. 279:1633-1633. 1998
Risk Factors for ICU-Acquired Pneumonia. 279:1605-1605. 1998
Does This Patient Have Deep Vein Thrombosis?. 279:1094-1094. 1998
Influence of Airway Management on Ventilator-Associated Pneumonia. 279:781-781. 1998
Users' Guides to the Medical Literature. 279:545-545. 1998
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism. 279:458-458. 1998
Using a Practice Guideline for Safely Shortening Hospital Stay for Upper Gastrointestinal Tract Hemorrhage. 278:2186-2186. 1997
Primary Angioplasty Compared With Thrombolytic Therapy for Acute Myocardial Infarction. 278:2110-2110. 1997
Primary angioplasty compared with thrombolytic therapy for acute myocardial infarction. 278:2110-2111. 1997
Evidence-based disease management. 278:1687-1692. 1997
Prevalence of child physical and sexual abuse in the community - Results from the Ontario health supplement. 278:131-135. 1997
Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. 278:131-135. 1997
The Negative Side of Cost-effectiveness Analysis-Reply. 277:1933-1933. 1997
The negative side of cost-effectiveness analysis.. 277:1931-1932. 1997
Users' Guides to the Medical Literature. 277:1802-1802. 1997
Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. 277:1802-1806. 1997
Users' Guides to the Medical Literature. 277:1552-1552. 1997
Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. 277:1552-1557. 1997
Users' Guides to the Medical Literature. 277:1232-1232. 1997
Users' guides to the medical literature .12. How to use articles about health-related quality of life. 277:1232-1237. 1997
Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. 277:1232-1237. 1997
Reporting Cost-effectiveness Analyses With Confidence-Reply. 277:375-375. 1997
Reporting cost-effectiveness analyses with confidence.. 277:375. 1997
Extremely low-birth-weight infants at adolescence: health status and quality of life. 276:1722-1723. 1996
Dietary Calcium Supplementation and Blood Pressure-Reply. 276:1386-1386. 1996
Dietary calcium supplementation and blood pressure.. 276:1385-1386. 1996
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: A meta-analysis of randomized controlled trials (vol 275, pg 1113, 1996). 276:1388-1388. 1996
Effects of Calcium Supplementation on Pregnancy-Induced Hypertension-Reply. 276:1388-1388. 1996
Self-perceived health status and health-related quality of life of extremely low-birth-weight infants at adolescence. 276:453-459. 1996
Users' guides to the medical literature .11. How to use an article about a clinical utilization review. 275:1435-1439. 1996
Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group. 275:1435-1439. 1996
Users' guides to the medical literature .9. A method for grading health care recommendations (vol 274, pg 1800, 1995). 275:1232-1232. 1996
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia - A meta-analysis of randomized controlled trials. 275:1113-1117. 1996
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. 275:1113-1117. 1996
Effects of dietary calcium supplementation on blood pressure - A meta-analysis of randomized controlled trials. 275:1016-1022. 1996
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. 275:1016-1022. 1996
The Rational Clinical Examination. Does this patient have abnormal central venous pressure?. 275:630-634. 1996
Users' Guides to the Medical Literature. 275:554-554. 1996
Users' guides to the medical literature .10. How to use an article reporting variations in the outcomes of health services. 275:554-558. 1996
Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group. 275:554-558. 1996
Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. 275:308-314. 1996
Evaluation of the Infertile Couple-Reply. 275:185-185. 1996
USERS GUIDES TO THE MEDICAL LITERATURE .9. A METHOD FOR GRADING HEALTH-CARE RECOMMENDATIONS. 274:1800-1804. 1995
Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. 274:1800-1804. 1995
USERS GUIDES TO THE MEDICAL LITERATURE .8. HOW TO USE CLINICAL-PRACTICE GUIDELINES .B. WHAT ARE THE RECOMMENDATIONS AND WILL THEY HELP YOU IN CARING FOR YOUR PATIENTS. 274:1630-1632. 1995
Users' Guides to the Medical Literature. 274:1630-1630. 1995
Users' guides to the Medical Literature. VIII. How to use clinical practice guidelines. B. what are the recommendations and will they help you in caring for your patients? The Evidence-Based Medicine Working Group. 274:1630-1632. 1995
A couple with infertility. 274:1159-1164. 1995
Changing physician performance. A systematic review of the effect of continuing medical education strategies. 274:700-705. 1995
USERS GUIDES TO THE MEDICAL LITERATURE .8. HOW TO USE CLINICAL-PRACTICE GUIDELINES .A. ARE THE RECOMMENDATIONS VALID. 274:570-574. 1995
Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. 274:570-574. 1995
OVERVIEW OF RANDOMIZED TRIALS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON MORTALITY AND MORBIDITY IN PATIENTS WITH HEART-FAILURE (VOL 273, PG 1450, 1995). 274:462-462. 1995
Withdrawing life support in Canada and the United States. 274:384-384. 1995
Another View on Overviews-Reply. 274:218-218. 1995
Developmental Care for Very Low-Birth-Weight Infants. 273:1576-1576. 1995
USERS GUIDES TO THE MEDICAL LITERATURE .7. HOW TO USE A CLINICAL DECISION-ANALYSIS .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS. 273:1610-1613. 1995
Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. 273:1610-1613. 1995
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure. 273:1450-1450. 1995
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. 273:1450-1456. 1995
The Quality of Quality-of-Life Measurements-Reply. 273:844-844. 1995
DETERMINANTS IN CANADIAN HEALTH-CARE WORKERS OF THE DECISION TO WITHDRAW LIFE-SUPPORT FROM THE CRITICALLY ILL. 273:703-708. 1995
Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. 273:703-708. 1995
Rote learning in medical school. 272:1380-1381. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .6. HOW TO USE AN OVERVIEW. 272:1367-1371. 1994
Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. 272:1367-1371. 1994
Health Status, Quality of Life, and the Individual. 272:630-630. 1994
Health status, quality of life, and the individual. 272:630-631. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .5. HOW TO USE AN ARTICLE ABOUT PROGNOSIS. 272:234-237. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .4. HOW TO USE AN ARTICLE ABOUT HARM. 271:1615-1619. 1994
Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. 271:1615-1619. 1994
Prevention of functional impairment by endarterectomy for symptomatic high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. 271:1256-1259. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS. 271:703-707. 1994
Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. 271:703-707. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .A. ARE THE RESULTS OF THE STUDY VALID. 271:389-391. 1994
Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. 271:389-391. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .2. HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION .B. WHAT WERE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS. 271:59-63. 1994
Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. 271:59-63. 1994
USERS GUIDES TO THE MEDICAL LITERATURE .2. HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION .A. ARE THE RESULTS OF THE STUDY VALID. 270:2598-2601. 1993
Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. 270:2598-2601. 1993
USERS GUIDES TO THE MEDICAL LITERATURE .1. HOW TO GET STARTED. 270:2093-2095. 1993
Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. 270:2093-2095. 1993
PREDICTION OF MORTALITY AND MORBIDITY WITH A 6-MINUTE WALK TEST IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION. 270:1702-1707. 1993
Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. 270:1702-1707. 1993
EFFECTS OF PROPHYLACTIC ANTIARRHYTHMIC DRUG-THERAPY IN ACUTE MYOCARDIAL-INFARCTION - AN OVERVIEW OF RESULTS FROM RANDOMIZED CONTROLLED TRIALS. 270:1589-1595. 1993
Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. 270:1589-1595. 1993
Competency assessment of primary care physicians as part of a peer review program. 270:1046-1051. 1993
SHOULD UNPUBLISHED DATA BE INCLUDED IN METAANALYSES - CURRENT CONVICTIONS AND CONTROVERSIES. 269:2749-2753. 1993
Should unpublished data be included in meta-analyses? Current convictions and controversies. 269:2749-2753. 1993
The rational clinical examination. Is this patient taking the treatment as prescribed?. 269:2779-2781. 1993
Evidence-Based Medicine: A New Paradigm for the Patient-Reply. 269:1254-1254. 1993
Evidence-Based Medicine. 268:2420-2420. 1992
Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. 268:1111-1117. 1992
An Overview of Interventions to Improve Compliance With Appointment Keeping for Medical Services. 267:1813-1813. 1992
An overview of interventions to improve compliance with appointment keeping for medical services. 267:1813-1817. 1992
Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials. 266:93-93. 1991
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. 266:93-98. 1991
Exposing Patients With Chronic, Stable, Exertional Angina to Placebo Periods in Drug Trials. 265:1550-1550. 1991
Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials. 265:1550-1554. 1991
Effectiveness of Intermittent Pneumatic Leg Compression for Preventing Deep Vein Thrombosis After Total Hip Replacement. 263:2313-2313. 1990
Attempting to ensure physician competence. 263:2041-2042. 1990
CONSUMPTION OF OLIVE OIL, BUTTER, AND VEGETABLE-OILS AND CORONARY HEART-DISEASE RISK-FACTORS. 263:688-692. 1990
Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. The Research Group ATS-RF2 of the Italian National Research Council. 263:688-692. 1990
Randomized Clinical Trials in Heart Disease-Reply. 261:2953-2953. 1989
Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. 260:2879-2882. 1988
OVERVIEW OF RESULTS OF RANDOMIZED CLINICAL-TRIALS IN HEART-DISEASE .2. UNSTABLE ANGINA, HEART-FAILURE, PRIMARY PREVENTION WITH ASPIRIN, AND RISK FACTOR MODIFICATION. 260:2259-2263. 1988
Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. 260:2259-2263. 1988
OVERVIEW OF RESULTS OF RANDOMIZED CLINICAL-TRIALS IN HEART-DISEASE .1. TREATMENTS FOLLOWING MYOCARDIAL-INFARCTION. 260:2088-2093. 1988
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. 260:2088-2093. 1988
EFFECTS OF PROPHYLACTIC LIDOCAINE IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - AN OVERVIEW OF RESULTS FROM THE RANDOMIZED, CONTROLLED TRIALS. 260:1910-1916. 1988
Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. 260:1910-1916. 1988
A randomized trial of a family physician intervention for smoking cessation. 260:1570-1574. 1988
Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. 260:945-950. 1988
The role of evidence in the consensus process. Results from a Canadian consensus exercise. 259:3001-3005. 1988
The optimal intensity of oral anticoagulant therapy. 258:2723-2726. 1987
A Controlled Trial of Teaching Critical Appraisal of the Clinical Literature to Medical Students. 257:2451-2451. 1987
A controlled trial of teaching critical appraisal of the clinical literature to medical students. 257:2451-2454. 1987
DEEP VENOUS THROMBOSIS - WHEN TO START ORAL-THERAPY. 257:2086-2087. 1987
Functional status changes following medical or surgical treatment for cerebral ischemia. Results of the extracranial-intracranial bypass study. 257:2043-2046. 1987
Intracranial Hemorrhage After Cocaine Abuse. 257:1175-1175. 1987
CONVERSION TO SI UNITS - THE CANADIAN EXPERIENCE. 256:3001-3002. 1986
Conversion to SI units. The Canadian experience. 256:3001-3002. 1986
ASPIRIN THERAPY FOR CORONARY-ARTERY DISEASE. 256:1802-1802. 1986
Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. 255:501-504. 1986
Mortality and Cancer Frequency Among Military Nuclear Test (Smoky) Participants. 252:627-627. 1984
A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis. 252:235-239. 1984
New Approaches for Deep Vein Thrombosis Occurring After Surgery. 251:2985-2985. 1984
Assessing the Effectiveness of Community Screening Programs. 251:1580-1580. 1984
A critical appraisal of the efficacy of continuing medical education. 251:61-64. 1984
Pulmonary infiltrates associated with naproxen. 251:65-66. 1984
Physical and Emotional Function of Primary Care Patients: Scientific Requirements for the Measurement of Functional Health Status. 249:3353-3353. 1983
Physical and emotional function of primary care patients: scientific requirements for the measurement of functional health status. 249:3353-3355. 1983
High-altitude retinopathy. 245:581-586. 1981
Vaccination-Associated relapse of immune thrombocytopenia. 245:369-370. 1981
Thrombocytopenia found uncommonly during heparin therapy. 241:2396-2397. 1979
Digitalis Toxicity Manifested by Dysphagia. 239:613-613. 1978
ANTICOAGULANT THERAPY AND RECURRENT VENOUS-THROMBOSIS. 240:284-284. 1978
Prevention of venous thrombosis with small, subcutaneous doses of heparin. 235:1980-1982. 1976
125-I-labeled fibrinogen scanning. Use in the diagnosis of venous thrombosis. 233:970-973. 1975
Dextroamphetamine treatment of depressed elderly woman. 221:721b-721. 1972

Journal of the American Medical Association (JAMA) Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)